See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Martin Midstream Partners L.P. (MMLP) - free report >>
Can-Fite Biopharma Ltd (CANF) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Martin Midstream Partners L.P. (MMLP) - free report >>
Can-Fite Biopharma Ltd (CANF) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 28th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 28th:
Martin Midstream Partners L.P. (MMLP - Free Report) : This company that engages in the terminalling, processing, storage, and packaging of petroleum products and by-products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Martin Midstream Partners L.P. Price and Consensus
Martin Midstream Partners L.P. price-consensus-chart | Martin Midstream Partners L.P. Quote
Martin Midstream Partners’ shares gained more than 100% over the last one month compared with the S&P 500 growth 14.7%. The company possesses a Momentum Score of A.
Martin Midstream Partners L.P. Price
Martin Midstream Partners L.P. price | Martin Midstream Partners L.P. Quote
Pixelworks, Inc. (PXLW - Free Report) : This company that develops and markets semiconductor and software solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
Pixelworks, Inc. Price and Consensus
Pixelworks, Inc. price-consensus-chart | Pixelworks, Inc. Quote
Pixelworks’ shares gained 43.8% over the last one month. The company possesses a Momentum Score of A.
Pixelworks, Inc. Price
Pixelworks, Inc. price | Pixelworks, Inc. Quote
Can-Fite BioPharma Ltd. (CANF - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.9% over the last 60 days.
Can-Fite Biopharma Ltd Price and Consensus
Can-Fite Biopharma Ltd price-consensus-chart | Can-Fite Biopharma Ltd Quote
Can-Fite BioPharma’s shares gained 38.1% over the last one month. The company possesses a Momentum Score of A.
Can-Fite Biopharma Ltd Price
Can-Fite Biopharma Ltd price | Can-Fite Biopharma Ltd Quote
Abeona Therapeutics Inc. : This a clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 60 days.
Abeona Therapeutics Inc. Price and Consensus
Abeona Therapeutics Inc. price-consensus-chart | Abeona Therapeutics Inc. Quote
Abeona Therapeutics’ shares gained 22.8% over the last one month. The company possesses a Momentum Score of A.
Abeona Therapeutics Inc. Price
Abeona Therapeutics Inc. price | Abeona Therapeutics Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>